Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or

Spectranetics Cp T (SPNC) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview as of [[ item.timeDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 943,990
  • Shares Outstanding, K 42,960
  • Annual Sales, $ 245,960 K
  • Annual Income, $ -59,470 K
  • 36-Month Beta 1.68
  • Price/Sales 3.95
  • Price/Book 11.66

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.55 +8.27%
on 11/04/16
24.35 -8.62%
on 11/21/16
+0.15 (+0.68%)
since 11/02/16
3-Month
19.80 +12.37%
on 11/02/16
25.52 -12.81%
on 10/05/16
-2.61 (-10.50%)
since 09/02/16
52-Week
11.09 +100.63%
on 02/12/16
25.81 -13.79%
on 08/11/16
+8.06 (+56.80%)
since 12/02/15

Most Recent Stories

More News
Spectranetics Receives CE Mark for Stellarex(TM) 0.014" Drug-Coated Balloon

The Spectranetics Corporation (NASDAQ:SPNC) today announced that its Stellarex(TM) 0.014" Drug-coated Angioplasty Balloon (DCB) has received the CE mark. The Stellarex 0.014" device is designed to treat...

Technical Reports on Medical Equipment Equities -- Lantheus, Nevro, Steris, and Spectranetics

Stock-Callers.com redirects investors' attention to the Medical Appliances and Equipment industry which is engaged in the manufacture of medical instruments such as dental and surgical appliances. Companies...

QT Vascular Announces That The Federal Circuit Denies AngioScore Petition For Rehearing

QT Vascular Ltd. (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), is a global company engaged in the design, assembly and distribution of advanced therapeutic solutions...

Spectranetics to Attend Upcoming Investor Conferences

The Spectranetics Corporation (NASDAQ:SPNC), ("the Company") today announced that company management will be attending three upcoming investor conferences.

Stellarex(TM) ILLUMENATE Pivotal Results Are Top-tier in the Most Complex Patient Group Studied in DCB IDE Trials

The Spectranetics Corporation (NASDAQ:SPNC) today announced that Dr. Sean Lyden presented the final 12-month results of the Stellarex Drug-coated Balloon (DCB) ILLUMENATE Pivotal Trial at the Transcatheter...

Spectranetics Files PMA Application for FDA Approval of the Stellarex(TM) Drug-Coated Balloon

The Spectranetics Corporation (NASDAQ:SPNC) announced today that it has submitted to the Food & Drug Administration (FDA) its Pre-Market Approval (PMA) application for the Stellarex drug-coated angioplasty...

Spectranetics Reports Third Quarter 2016 Revenue of $68.3 million

The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three months ended September 30, 2016. Highlights of the quarter, all compared with the three months ended September...

Shares of SPNC Up 18.3% Since Uptrend Call on Shares

SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on July 7th, 2016 at $19.95. In approximately 3 months, Spectranetics has returned 18.33% as of today's recent price of $23.60.

Spectranetics Up 18.6% Since SmarTrend Uptrend Call (SPNC)

SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on July 7th, 2016 at $19.95. In approximately 3 months, Spectranetics has returned 18.58% as of today's recent price of $23.65.

Spectranetics Announces Third Quarter 2016 Conference Call and Upcoming Webcast at the Transcatheter Cardiovascular Therapeutics Conference

The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release third quarter 2016 financial results after the market close on Thursday, October 27, 2016. Company management will...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Spectranetics Corp. is a medical device company engaged in the development, manufacturing, marketing and distribution of its technology for interventional cardiovascular therapy. The Company's CVX-300 excimer laser system is the only excimer laser system approved by the FDA for multiple cardiovascular...

See More

Support & Resistance

2nd Resistance Point 23.08
1st Resistance Point 22.67
Last Price 22.25
1st Support Level 21.97
2nd Support Level 21.68

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.